Sensitive determination of 4-O-methylhonokiol in rabbit plasma by high performance liquid chromatography and application to its pharmacokinetic investigation

Journal of Pharmaceutical Analysis

Volumn 1, Issue 2, 2011, Pages 108-112

  Li, Ming Yue ^a   Tang, Yu Hai ^a   Liu, Xia ^a   Lü, Hai Yan ^a   Shi, Xi Yan ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

4 O methylhonokiol; Cortex magnoliae officinalis; High performance liquid chromatography; Pharmacokinetic

Indexed keywords

4 O METHYLHONOKIOL; AMMONIUM FORMATE; HONOKIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CHEMICAL STRUCTURE; DRUG ANALYSIS; ENVIRONMENTAL TEMPERATURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; MOLECULAR STABILITY; NONHUMAN; PHARMACOKINETICS; QUALITY CONTROL; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE;

MAGNOLIA OFFICINALIS; ORYCTOLAGUS CUNICULUS;

EID: 84925835426     PISSN: 20951779     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2095-1779(11)70019-3     Document Type: Article

References (17)

1. Chinese Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China. Chemical Industry Press, Beijing, China, 2005:76-177. (in Chinese)
2. Editorial Committee of Chinese Materia Medica. Chinese Materia Medica. Shanghai Science and Technology Press, Shanghai, China, 1999:423-432. (in Chinese)
3. Park J, Lee J, Jung ES, et al. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol, 2004,496(1-3):189-195. (Pubitemid 39024332)
4. Ogata M, Hoshi M, Shimotohno K, et al. Antioxidant activity of Magnolol, Honokiol, and related Phenolic compounds. J Am Oil Chem Soc, 1997,74:557-562. (Pubitemid 127553535)
5. Ikeda K, Sakai Y, Nagase H. Inhibitory effect of magnolol on tumour metastasis in mice. Phytother Res, 2003,17(8):933-937. (Pubitemid 37152762)
6. Ho KY, Tsai CC, Chen CP, et al. Antimicrobial activity of Honokiol and Magnolol isolated from Magnolia officinalis. Phytother Res, 2001,15(2):139-141.
7. Tsai SK, Huang CH, Huang SS, et al. Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: Influence of L-NAME and aspirin. Pharmacology, 1999,59(5):227-233. (Pubitemid 29473847)
8. Pyo MK, Lee YY, Yun-Choi HS. Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res, 2002,25(3):325-328.
9. κB. Chem Biol Interact, 2009,180(1):506-514.
10. Lee YK, Choi IS, Kim YH, et al. Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation. Neurochem Res, 2009,34(12):2251-2260.
11. Lee YK, Yuk DY, Kim TI, et al. Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J Nat Med, 2009,63(3):274-282.
12. Wang BQ. Study of quality standard and standard substance of Chinese prepared medicine. Chinese Curative Science and Technology Press, Beijing, China, 1994:518-521. (in Chinese)
13. Zhao LH. Handbook of composition analysis of Chinese drugs by HPLC. Chinese Curative Science and Technology Press, Beijing, China, 1994:443-452. (in Chinese)
14. Yahara S, Nishiyori T, Kohda A, et al. Isolation and characterization of phenolic compounds from Magnoliae cortex produced in China. Chem Pharm Bull, 1991,39(8):2024-2036.
15. Rao KV, Davis TL. Constituents of Magnolia grandiflora I: Mono-O-methylhonokiol. Planta Med, 1982,45(5):57-59. (Pubitemid 12063510)
16. κB, JNK and p38 MAPK inactivation. Eur J Pharmacol, 2008,586(1-3):340-349.
17. USFDA. 2001. http://www.fda.gov/cder/guidance/4252fnl.htm.